Clinical Trials
4 trialsNCT04673175 2026-01-21
Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
Weill Medical College of Cornell University
Phase 4 Terminated
NCT03469271 2023-09-26
Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients
Mayo Clinic
Phase 4 Completed
NCT04381494 2023-06-22
ON TRAX
AstraZeneca
Phase 4 Terminated
NCT04036721 2023-02-23
PROS-CONS
National Institute for Tuberculosis and Lung Diseases, Poland
Phase 4 Suspended